![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
A Roca-Cusachs, DJ DiPette and GA Nickols
Department of Medicine, University of Texas Medical Branch, Galveston.
It has been demonstrated previously that parathyroid hormone-related protein (PTHrp) has potent vasodilatory and cardiac stimulatory properties. However, the systemic and regional hemodynamic effects of PTHrp are unknown. In order to characterize these effects, we utilized the radioactive microsphere technique to examine the systemic and regional hemodynamics before and 2 min after the i.v. bolus administration of 0.03, 0.3 and 3.0 micrograms/ml/100 g b.wt. of PTHrp in conscious, unrestrained, normal rats. These effects were compared to those of synthetic rat parathyroid hormone (PTH), an agent known to affect cardiovascular function. PTHrp and PTH similarly and significantly decreased mean systemic blood pressure and total peripheral resistance but increased heart rate and cardiac output, all in a dose-dependent manner. Both peptides increased blood flow and decreased vessel resistance in regional vascular beds such as skin and heart. Renal resistance was reduced by PTH and PTHrp, but renal blood flow was not altered. Conversely, both peptides significantly decreased blood flow and increased vascular resistance to the splanchnic organs. Thus, PTHrp as well as PTH, preserved and enhanced cardiac function in the face of reduced systemic blood pressure while maintaining renal flow. These features are highly desirable in the treatment of some severe cardiovascular abnormalities. These results are consistent with the hypothesis that PTHrp may play an important hormonal, autocrine or paracrine role in systemic and regional blood flow regulation.
This article has been cited by other articles:
|
|
 |
|
  M.-M. Zaruba, B. C. Huber, S. Brunner, E. Deindl, R. David, R. Fischer, G. Assmann, N. Herbach, S. Grundmann, R. Wanke, et al. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival Cardiovasc Res, March 1, 2008; 77(4): 722 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. K. Leong, L. E. Yang, H. W. Lin, N. H. Holstein-Rathlou, and A. A. McDonough Acute hypotension induced by aortic clamp vs. PTH provokes distinct proximal tubule Na+ transporter redistribution patterns Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R878 - R885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jansen, P. Gres, C. Umschlag, F. R. Heinzel, H. Degenhardt, K.-D. Schluter, G. Heusch, and R. Schulz Parathyroid hormone-related peptide improves contractile function of stunned myocardium in rats and pigs Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H49 - H55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ogino, K. Ogura, Y. Kinugasa, Y. Furuse, K. Uchida, M. Shimoyama, T. Kinugawa, S. Osaki, M. Kato, Y. Tomikura, et al. Parathyroid Hormone-Related Protein Is Produced in the Myocardium and Increased in Patients with Congestive Heart Failure J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4722 - 4727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hara, Y.-M. Liu, L. Zhen, I. S. Cohen, H. Yu, P. Danilo Jr, K. Ogino, J. P. Bilezikian, and M. R. Rosen Positive Chronotropic Actions of Parathyroid Hormone and Parathyroid Hormone–Related Peptide Are Associated With Increases in the Current, If, and the Slope of the Pacemaker Potential Circulation, November 18, 1997; 96(10): 3704 - 3709. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Jiang, S. Morimoto, J. Yang, K. Fukuo, A. Hirotani, S. Kitano, and T. Ogihara Parathyroid Hormone–Related Protein Upregulates Interleukin-1ß–Induced Nitric Oxide Synthesis Hypertension, October 1, 1997; 30(4): 922 - 927. [Abstract] [Full Text]
|
|
|
|
|
|
M. Wolzt, L. Schmetterer, G. Dorner, G. Zelger, J. Entlicher, S. Kapiotis, and H.-G. Eichler Hemodynamic Effects of Parathyroid Hormone-Related Peptide-(1-34) in Humans J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2548 - 2551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jono, Y. Nishizawa, A. Shioi, and H. Morii Parathyroid Hormone–Related Peptide as a Local Regulator of Vascular Calcification: Its Inhibitory Action on In Vitro Calcification by Bovine Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1135 - 1142. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Yamamoto, I. Morimoto, N. Yanagihara, K. Zeki, T. Fujihira, F. Izumi, H. Yamashita, and S. Eto Parathyroid Hormone-Related Peptide-(1-34) [PTHrP- (1-34)] Induces Vasopressin Release from the Rat Supraoptic Nucleus in Vitro through a Novel Receptor Distinct from a Type I or Type II PTH/PTHrP Receptor Endocrinology, May 1, 1997; 138(5): 2066 - 2072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Amizuka, H. S. Lee, M. Y. Kwan, A. Arazani, H. Warshawsky, G. N. Hendy, H. Ozawa, J. H. White, and D. Goltzman Cell-Specific Expression of the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene in Kidney from Kidney-Specific and Ubiquitous Promoters Endocrinology, January 1, 1997; 138(1): 469 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Jiang, S. Morimoto, K. Fukuo, A. Hirotani, M. Tamatani, T. Nakahashi, A. Nishibe, T. Niinobu, S. Hata, S. Chen, et al. Parathyroid Hormone–Related Protein Inhibits Endothelin-1 Production Hypertension, March 1, 1996; 27(3): 360 - 363. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
